Bayer non-cystic fibrosis bronchiectasis treatment gets FDA orphan designation

theflyonthewall.com

According to a post on the FDA's website, Bayer's ciprofloxacin dry powder inhaler to treat non-cystic fibrosis bronchiectasis received orphan designation.

Rates

View Comments (0)